Literature DB >> 10872475

Pathophysiology of thalassaemia.

D J Weatherall1.   

Abstract

Most of the major clinical manifestations of the beta-thalassaemias can be related to the deleterious effects of imbalanced globin chain synthesis on erythroid maturation and red cell survival. The destruction of red cell progenitors and their progeny results from an extremely complex series of mechanisms all related to the presence of excess alpha-globin chain production. These include mechanical damage, interference with cell division and oxidative destruction of both organelles and components of the red cell membrane. The unequal distribution of gamma-globin chains between different precursors, and the intense selection of those with relatively higher levels of gamma chain production, lead to an extremely heterogeneous cell population in the peripheral blood. Iron overload, due to increased gastrointestinal absorption and blood transfusion is the major cause of tissue damage, morbidity and death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10872475     DOI: 10.1016/s0950-3536(98)80072-3

Source DB:  PubMed          Journal:  Baillieres Clin Haematol        ISSN: 0950-3536


  34 in total

1.  Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients.

Authors:  Nuntiya Somparn; Upa Kukongviriyapan; Wichittra Tassaneeyakul; Arunee Jetsrisuparb; Veerapol Kukongviriyapan
Journal:  Eur J Clin Pharmacol       Date:  2006-11-21       Impact factor: 2.953

2.  Intestinal hypoxia-inducible factor-2alpha (HIF-2alpha) is critical for efficient erythropoiesis.

Authors:  Erik R Anderson; Xiang Xue; Yatrik M Shah
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

3.  Bone age estimation and prediction of final height in patients with beta-thalassaemia major: a comparison between the two most common methods.

Authors:  Athanasios Christoforidis; Maria Badouraki; George Katzos; Miranda Athanassiou-Metaxa
Journal:  Pediatr Radiol       Date:  2007-10-19

4.  LIN28B-mediated expression of fetal hemoglobin and production of fetal-like erythrocytes from adult human erythroblasts ex vivo.

Authors:  Y Terry Lee; Jaira F de Vasconcellos; Joan Yuan; Colleen Byrnes; Seung-Jae Noh; Emily R Meier; Ki Soon Kim; Antoinette Rabel; Megha Kaushal; Stefan A Muljo; Jeffery L Miller
Journal:  Blood       Date:  2013-06-24       Impact factor: 22.113

5.  Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.

Authors:  Huihui Li; Tenzin Choesang; Weili Bao; Huiyong Chen; Maria Feola; Daniel Garcia-Santos; Jie Li; Shuming Sun; Antonia Follenzi; Petra Pham; Jing Liu; Jinghua Zhang; Prem Ponka; Xiuli An; Narla Mohandas; Robert E Fleming; Stefano Rivella; Guiyuan Li; Yelena Z Ginzburg
Journal:  Blood       Date:  2017-02-01       Impact factor: 22.113

Review 6.  β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.

Authors:  Yelena Ginzburg; Stefano Rivella
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

7.  Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming.

Authors:  Orapan Sripichai; Christine M Kiefer; Natarajan V Bhanu; Toshihiko Tanno; Seung-Jae Noh; Sung-Ho Goh; J Eric Russell; Cheryl L Rognerud; Ching-Nan Ou; Patricia A Oneal; Emily R Meier; Nicole M Gantt; Colleen Byrnes; Y Terry Lee; Ann Dean; Jeffery L Miller
Journal:  Blood       Date:  2009-07-13       Impact factor: 22.113

Review 8.  Iron and diabetes risk.

Authors:  Judith A Simcox; Donald A McClain
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

9.  A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.

Authors:  Qiuying Chen; Mary E Fabry; Anne C Rybicki; Sandra M Suzuka; Tatiana C Balazs; Zipora Etzion; Kitty de Jong; Edna K Akoto; Joseph E Canterino; Dhananjay K Kaul; Frans A Kuypers; David Lefer; Eric E Bouhassira; Rhoda Elison Hirsch
Journal:  Blood Cells Mol Dis       Date:  2012-01-18       Impact factor: 3.039

10.  Immunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermedia.

Authors:  Weili Bao; Hui Zhong; Karina Yazdanbakhsh
Journal:  Transfusion       Date:  2014-05-05       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.